Joint Corp director granted 5,714 restricted shares

Grandpre Christopher M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Grandpre Christopher M reported acquisition or exercise transactions in this Form 4 filing.

JOINT Corp director Christopher M. Grandpre received an equity grant of 5,714 shares of Common Stock. The award was granted at no cash cost as restricted shares. All 5,714 shares vest in full on the earlier of May 20, 2027 or the next annual meeting of JOINT Corp stockholders. Following this grant, Grandpre directly holds a total of 45,097 Common Stock shares, reflecting a routine stock-based compensation award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 5,714 shares

Grant/Award 1 txn

Insider Grandpre Christopher M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,714	$0.00	$0.00

Holdings After Transaction: Common Stock — 45,097 shares (Direct)

Footnotes (1)

1. F1. All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027 and (ii) the date of the next annual meeting of the stockholders of The Joint Corp.

Key Figures

Restricted stock grant: 5,714 shares Grant price per share: $0.00 per share Total shares after grant: 45,097 shares +1 more

4 metrics

Restricted stock grant 5,714 shares Common Stock awarded on May 20, 2026

Grant price per share $0.00 per share Equity compensation award, not market purchase

Total shares after grant 45,097 shares Director’s direct Common Stock holdings post-transaction

Vesting date May 20, 2027 Vests earlier of this date or next annual stockholders’ meeting

Key Terms

restricted shares, vesting, annual meeting of the stockholders, Grant, award, or other acquisition

4 terms

restricted shares financial

"All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027..."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vesting financial

"restricted shares, with vesting in full on the earlier of (i) May 20, 2027..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of the stockholders financial

"the earlier of (i) May 20, 2027 and (ii) the date of the next annual meeting of the stockholders of The Joint Corp."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Joint Corp (JYNT) report for Christopher M. Grandpre?

Joint Corp reported that director Christopher M. Grandpre received a grant of 5,714 restricted Common Stock shares. The award was recorded on May 20, 2026 as a stock-based compensation grant, not an open-market purchase or sale.

How many Joint Corp (JYNT) shares did Christopher Grandpre receive in this Form 4?

Christopher Grandpre received 5,714 shares of Joint Corp Common Stock. These shares were granted as restricted stock with no cash paid per share, representing an equity compensation award rather than a market transaction.

When do Christopher Grandpre’s restricted Joint Corp (JYNT) shares vest?

All 5,714 restricted shares vest on the earlier of May 20, 2027 or the date of Joint Corp’s next annual stockholders’ meeting. This single vesting date structure ties the award to the company’s board service period.

How many Joint Corp (JYNT) shares does Christopher Grandpre hold after this grant?

After the grant, Christopher Grandpre directly holds 45,097 Joint Corp Common Stock shares. This total includes the newly awarded 5,714 restricted shares, which remain subject to vesting conditions until the applicable vesting date is reached.

Was Christopher Grandpre’s Joint Corp (JYNT) grant an open-market purchase?

No, the Form 4 shows a code “A” transaction, meaning a grant or award. The 5,714 Joint Corp shares were issued as restricted stock at a reported price of $0.00 per share, reflecting compensation rather than a market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grandpre Christopher M

(Last) (First) (Middle)

16767 NORTH PERIMETER DRIVE

SUITE 110

(Street)

SCOTTSDALE ARIZONA 85260

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOINT Corp [ JYNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		5,714(1)	A	$0	45,097	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. All of the shares are restricted shares, with vesting in full on the earlier of (i) May 20, 2027 and (ii) the date of the next annual meeting of the stockholders of The Joint Corp.

Remarks:

	/s/ Andra Terrell, as attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)